Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Molecular Evidence Development Consortium

Molecular Evidence Development Consortium

Fiscal year ending 2018. Filed on April 9, 2019.

343 E 4th Suite
Rexburg, Idaho 83440

Molecular Evidence Development Consortium (EIN: 47-2986038) has filed an IRS Form 990 from fiscal year 2016–2018. In its fiscal year 2018 IRS Form 990 filing, Molecular Evidence Development Consortium, a 501(c)(3) charitable organization, reported compensation for 2 out of 7 total employees. Among the employees shown here, the average compensation is $137,168. The highest compensated employee at Molecular Evidence Development Consortium is Dane J Dickson, M.D. with fiscal year 2018 compensation of $157,154.

Revenue, expenses, and employee compensation

Revenue

$343,299

Expenses

$865,406

Employee compensation

$241,043
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Dane J Dickson, M.D.
Chief Executive Officer
$157,154
$157,154 No related compNo other comp
Rebecca Owens
Chief Operating Officer
$117,181
$117,181 No related compNo other comp

Benchmark Employee Compensation

Non-Employee Board Members

Jeff Allen, Ph.D.
Chair
Marc Samuels, Jd
Board Member
Ron Collette, Cissp
Board Member

Contractors

Unosquare LLC
Software Development
$158,735

Mission Statement

MED-C WAS A NONPROFIT ORGANIZATION CREATED TO HELP MAKE PERSONALIZED MEDICINE A REALITY. MED-C WAS BRINGING TOGETHER EACH OF HEALTH CARE'S KEY GROUPS - PATIENT, PHYSICIANS, PAYORS, LABS, PHARMA AND REGULATORS TO HELP UNLOCK THE TREMENDOUS POTENTIAL OF PERSONALIZED MEDICINE. TO ACHIEVE THIS GOAL, MED-C HAD LAUNCHED A VAST DATABASE THAT GATHERED GENOMIC-LEVEL DATA ON CANCER PATIENTS AND THOROUGH INFORMATION ABOUT THEIR TREATMENTS AND CLINICAL OUTCOMES.UNFORTUNATELY DUE TO UNFORESEEABLE REGULATORY CIRCUMSTANCES MED-C HAD TO DISCONTINUE IT'S OPERATIONS.

Revisions to this organization profile

April 9, 2019:
2018 Molecular Evidence Development Consortium 990 filed
August 16, 2018:
2017 Molecular Evidence Development Consortium 990 filed
February 17, 2017:
2016 Molecular Evidence Development Consortium 990 filed

Get an email when new compensation information is released for Molecular Evidence Development Consortium

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →